Form 4/A for INKT MiNK Therapeutics, Inc.
Accepted 2025-10-03 00:00:00 ET · period of report 2025-09-09 · accession 0001193125-25-230098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-10-03 | 2025-09-09 | INKT | Buell Jennifer | CEO | F - Tax | $15.36 | -5,351 | 36.5K | -13% | -$82.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-09 | F | D | 5,351 | $15.36 | 36,492 | D | — | — | (F1) These shares were withheld for payment of the withholding taxes in relation to the stock issued to reporting person on September 9, 2025, as previously reported on the Form 4 filed on September 11, 2025 (the "Original Form 4"). The Original Form 4 did not include the shares withheld for payment of withholding taxes in Table I. This amendment is being filed to correct this error. |